Relevant issues in the pathology and pathobiology of pulmonary hypertension.

[1]  W. Kuebler,et al.  Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[2]  Sotirios D. Zervopoulos,et al.  A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension , 2013, Journal of Molecular Medicine.

[3]  Thomas A. Wynn,et al.  Macrophage biology in development, homeostasis and disease , 2013, Nature.

[4]  S. Archer,et al.  PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension. , 2013, American journal of respiratory and critical care medicine.

[5]  F. Bushman,et al.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.

[6]  James D. Thomas,et al.  Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year. , 2013, Annals of the American Thoracic Society.

[7]  E. Michelakis,et al.  Attenuating Endoplasmic Reticulum Stress as a Novel Therapeutic Strategy in Pulmonary Hypertension , 2013, Circulation.

[8]  W. Chung,et al.  A novel channelopathy in pulmonary arterial hypertension. , 2013, The New England journal of medicine.

[9]  M. Humbert,et al.  Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans. , 2012, American journal of respiratory cell and molecular biology.

[10]  B. Dahal,et al.  Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.

[11]  Changjin Lee,et al.  Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension , 2012, Circulation.

[12]  H. Hammad,et al.  Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.

[13]  M. Humbert,et al.  Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. , 2012, Arthritis and rheumatism.

[14]  Des C. Jones,et al.  Impaired Natural Killer Cell Phenotype and Function in Idiopathic and Heritable Pulmonary Arterial Hypertension , 2012, Circulation.

[15]  S. Hazen,et al.  Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension. , 2012, Blood.

[16]  S. Groshong,et al.  Modern age pathology of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.

[17]  R. Knight,et al.  Human Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension. , 2012, AIDS research and human retroviruses.

[18]  W. Chung,et al.  Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension , 2012, Circulation. Cardiovascular genetics.

[19]  S. Archer,et al.  Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary Hypertension , 2012, Circulation research.

[20]  D. Stewart,et al.  Genetically modified endothelial progenitor cells in the therapy of cardiovascular disease and pulmonary hypertension. , 2012, Current vascular pharmacology.

[21]  M. Yeager,et al.  Pulmonary Circulation | April-june 2012 | Vol 2 | No 2 Research Ar Ticle Activation of the Unfolded Protein Response Is Associated with Pulmonary Hypertension Gates Center for Regenerative Medicine and Stem Cell Biology , 2022 .

[22]  S. Archer,et al.  Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.

[23]  T. McKinsey,et al.  Selective Class I Histone Deacetylase Inhibition Suppresses Hypoxia-Induced Cardiopulmonary Remodeling Through an Antiproliferative Mechanism , 2012, Circulation research.

[24]  M. Humbert,et al.  Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension , 2012, European Respiratory Journal.

[25]  R. Tuder,et al.  Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension. , 2012, American journal of respiratory and critical care medicine.

[26]  M. Humbert,et al.  Inflammation in pulmonary arterial hypertension , 2003, European Respiratory Journal.

[27]  S. Erzurum,et al.  Complement C3 Deficiency Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension in Mice , 2011, PloS one.

[28]  M. Humbert,et al.  Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma , 2011, European Respiratory Journal.

[29]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[30]  J. Newman,et al.  High-altitude pulmonary hypertension in cattle (brisket disease): Candidate genes and gene expression profiling of peripheral blood mononuclear cells , 2011, Pulmonary circulation.

[31]  T. McKinsey,et al.  Emergence of Fibroblasts with a Proinflammatory Epigenetically Altered Phenotype in Severe Hypoxic Pulmonary Hypertension , 2011, The Journal of Immunology.

[32]  K. Clément,et al.  Krüppel-like factor 4 regulates macrophage polarization. , 2011, The Journal of clinical investigation.

[33]  W. Sessa,et al.  The Role of Nogo and the Mitochondria–Endoplasmic Reticulum Unit in Pulmonary Hypertension , 2011, Science Translational Medicine.

[34]  S. Erzurum,et al.  Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. , 2011, Blood.

[35]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[36]  E. Paquet,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[37]  G. Semenza,et al.  HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. , 2011, American journal of respiratory and critical care medicine.

[38]  M. Varella‐Garcia,et al.  Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension. , 2010, American journal of respiratory and critical care medicine.

[39]  K. Nakai,et al.  The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection , 2010, Nature Immunology.

[40]  R. Trembath,et al.  Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2010, Circulation.

[41]  N. Voelkel,et al.  Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension , 2010, Circulation.

[42]  Gene Kim,et al.  Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension: A Basis for Excessive Cell Proliferation and a New Therapeutic Target , 2010, Circulation.

[43]  G. Butrous,et al.  Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. , 2010, Chest.

[44]  E. K. Weir,et al.  Basic Science of Pulmonary Arterial Hypertension for Clinicians: New Concepts and Experimental Therapies , 2010, Circulation.

[45]  D. Tregouet,et al.  Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. , 2010, American journal of respiratory and critical care medicine.

[46]  B. Krishnamachary,et al.  Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells. , 2010, The American journal of pathology.

[47]  J. Albina,et al.  The phenotype of murine wound macrophages , 2010, Journal of leukocyte biology.

[48]  Kurt R Stenmark,et al.  Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[49]  W. Seeger,et al.  Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. , 2009, American journal of respiratory and critical care medicine.

[50]  Y. Dou,et al.  Epigenetic regulation of the alternatively activated macrophage phenotype. , 2009, Blood.

[51]  N. Weissmann,et al.  Cellular and molecular basis of pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.

[52]  P. Thistlethwaite,et al.  Development and pathology of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[53]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[54]  M. Humbert,et al.  Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. , 2009, The Journal of clinical investigation.

[55]  R. Matsuoka,et al.  A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension , 2009, Journal of Medical Genetics.

[56]  N. Morrell,et al.  Altered Bone Morphogenetic Protein and Transforming Growth Factor-β Signaling in Rat Models of Pulmonary Hypertension: Potential for Activin Receptor-Like Kinase-5 Inhibition in Prevention and Progression of Disease , 2009, Circulation.

[57]  M. Humbert,et al.  Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.

[58]  M. Humbert,et al.  Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.

[59]  P. Sehgal,et al.  Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension. , 2008, American journal of respiratory and critical care medicine.

[60]  S. Erzurum,et al.  Copyright © American Society for Investigative Pathology DOI: 10.2353/ajpath.2008.070705 Cardiovascular, Pulmonary and Renal Pathology Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial Hypertension , 2022 .

[61]  M. Maitland,et al.  Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. , 2008, American journal of physiology. Heart and circulatory physiology.

[62]  A. Zaiman,et al.  Role of TGF-β/ALK5 kinase in Monocrotaline-Induced Pulmonary Hypertension , 2008 .

[63]  R. Speich,et al.  Increased Regulatory and Decreased CD8+ Cytotoxic T Cells in the Blood of Patients with Idiopathic Pulmonary Arterial Hypertension , 2007, Respiration.

[64]  S. Erzurum,et al.  Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[65]  P. Sehgal,et al.  Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs? , 2007, American journal of physiology. Heart and circulatory physiology.

[66]  N. Voelkel,et al.  Rho Kinase-Mediated Vasoconstriction Is Important in Severe Occlusive Pulmonary Arterial Hypertension in Rats , 2007, Circulation research.

[67]  R. Tuder,et al.  Pathology of pulmonary hypertension. , 2007, Clinics in chest medicine.

[68]  Kazuto Nakamura,et al.  Diverse Contribution of Bone Marrow-Derived Cells to Vascular Remodeling Associated With Pulmonary Arterial Hypertension and Arterial Neointimal Formation , 2007, Circulation.

[69]  Raed A Dweik,et al.  Alterations of cellular bioenergetics in pulmonary artery endothelial cells , 2007, Proceedings of the National Academy of Sciences.

[70]  M. Clatworthy,et al.  Neutrophils from patients with heterozygous germline mutations in the von Hippel Lindau protein (pVHL) display delayed apoptosis and enhanced bacterial phagocytosis. , 2006, Blood.

[71]  Eric W. Glissmeyer,et al.  Relationship of BMPR2 Mutations to Vasoreactivity in Pulmonary Arterial Hypertension , 2006, Circulation.

[72]  M. Frid,et al.  Role of the adventitia in pulmonary vascular remodeling. , 2006, Physiology.

[73]  M. Frid,et al.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. , 2006, The American journal of pathology.

[74]  J. Carlquist,et al.  Mutations of the TGF‐β type II receptor BMPR2 in pulmonary arterial hypertension , 2006, Human mutation.

[75]  A. Zaiman,et al.  One hundred years of research in the pathogenesis of pulmonary hypertension. , 2005, American journal of respiratory cell and molecular biology.

[76]  W. Seeger,et al.  Reversal of experimental pulmonary hypertension by PDGF inhibition. , 2005, The Journal of clinical investigation.

[77]  M. Humbert,et al.  Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension , 2005, Thorax.

[78]  P. Jones,et al.  Epidermal Growth Factor Receptor Blockade Mediates Smooth Muscle Cell Apoptosis and Improves Survival in Rats With Pulmonary Hypertension , 2005, Circulation.

[79]  S. Archer,et al.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. , 2005, The Journal of clinical investigation.

[80]  J. Dyck,et al.  Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis , 2004, Circulation research.

[81]  M. Humbert,et al.  Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension , 2004, Thorax.

[82]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[83]  M. Humbert,et al.  Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.

[84]  J. Lord,et al.  Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. , 2001, Trends in immunology.

[85]  N. Voelkel,et al.  Microsatellite Instability of Endothelial Cell Growth and Apoptosis Genes Within Plexiform Lesions in Primary Pulmonary Hypertension , 2001, Circulation research.

[86]  S. Hodge,et al.  Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.

[87]  R. Trembath,et al.  Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.

[88]  N. Chandel,et al.  Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia , 2000, The Journal of Biological Chemistry.

[89]  Adrian M Heilbut,et al.  Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor , 2000, Nature Medicine.

[90]  J. Polak,et al.  Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[91]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[92]  P. Jones,et al.  Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. , 2000, The Journal of clinical investigation.

[93]  M. Carson,et al.  Integrating innate and adaptive immunity in the whole animal , 1999, Immunological reviews.

[94]  N. Voelkel,et al.  Primary pulmonary hypertension between inflammation and cancer. , 1998, Chest.

[95]  N. Voelkel,et al.  Pulmonary hypertension and inflammation. , 1998, The Journal of laboratory and clinical medicine.

[96]  K. Shroyer,et al.  Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. , 1998, The Journal of clinical investigation.

[97]  M. Humbert,et al.  Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.

[98]  B. Groves,et al.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. , 1994, The American journal of pathology.

[99]  D. H. Will,et al.  Embryo Transplanted Calves: The Pulmonary Hypertensive Trait Is Genetically Transmitted , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[100]  E. K. Weir,et al.  The genetic factor influencing pulmonary hypertension in cattle at high altitude. , 1974, Cardiovascular research.